Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Concord Biotech Ltd - 543960 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and as per the company''s code of conduct for regulating, monitoring and reporting of trading by insiders, the trading window for trading in the equity shares of the company will be closed from January 01, 2024 till the expiry of 48 hours after the declaration of the unaudited financial results for the quarter and nine months ended December 31, 2023.
29-12-2023
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be Meeting Investors (Participants) as per below schedule enclosed in the file. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Participants / Host / Company.
14-12-2023
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below: Date Type of Interaction Venue 24th November 2023 Plant Visit & Meeting Limbasi and Valthera Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 (6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Participants / Company.
20-11-2023
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 In Continuation of our letter dated November 09, 2023 regarding audio recording of the Unaudited (Standalone and consolidated) Financial results of the company for the quarter and half year ended September 30, 2023, Earnings call for investors and analysts and pursuant to regulation 30(6) of SEBI LODR, the transcripts of the earning call for the said period enclosed herewith.
16-11-2023
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated October 31, 2023 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Quarter and half year ended September 30, 2023, we wish to inform that the said Earning Call was held today at 03:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q2FY24-Earnings-call-audio.mp3 Kindly take the above on records
09-11-2023
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 09, Pursuant to regulation 47 of the SEBI (LODR) Regulations, 2015, Please find enclosed herewith extracts of the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2023 as published in the below newspapers on November 09, 2023 in Financial express in all editions English language and Ahmedabad edition in Gujarati language. the said results were also uploaded on the website of the company at www.concordbiotech.com
09-11-2023
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to regulation 30 of Schedule III Part A of SEBI (Listing Obligations and disclosure requirements) Regulations, 2015, investors presentation on financial results for the quarter and half year ended on September 30, 2023 is enclosed.
08-11-2023
Bigul

Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Wednesday, November 08, 2023- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023

 With reference to the intimation of Board meeting submitted on October 25, 2023, we would like to inform you that the Board of Directors of the Company, at its meeting held today i.e. Wednesday, November 08, 2023, has inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2023. The said results were also reviewed by the Audit Committee of the Company in its meeting held on November 08, 2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023, along with the Limited Review Report of the Statutory auditors. The Board Meeting commenced at 11:00 AM and concluded at 03:00 P.M.
08-11-2023
Bigul

Concord Biotech Ltd - 543960 - Outcome Of Board Meeting Held Today I.E Wednesday, November 08, 2023- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023

 we would like to inform you that the Board of Directors of the company at its meeting held today i.e. Wednesday, 08th November, 2023 has inter-alia approved unaudited standalone and consolidated financial results for the quarter and half year ended september 30, 2023. the said results were also reviewed by the audit committee of the company in its meeting held on 08th November, 2023
08-11-2023

Concord Biotech Share Price Live blog for 06 Nov 2023

 Concord Biotech stock price went up today, 06 Nov 2023, by 1.23 %. The stock closed at 1130.05 per share. The stock is currently trading at 1143.95 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.
06-11-2023
Next Page
Close

Let's Open Free Demat Account